PortfoliosLab logoPortfoliosLab logo
SOC vs. MLTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SOC vs. MLTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sable Offshore Corp (SOC) and MoonLake Immunotherapeutics (MLTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SOC achieves a 45.45% return, which is significantly higher than MLTX's 36.57% return.


SOC

1D
7.10%
1M
2.10%
YTD
45.45%
6M
133.87%
1Y
-46.45%
3Y*
5Y*
10Y*

MLTX

1D
0.56%
1M
5.51%
YTD
36.57%
6M
19.44%
1Y
-61.60%
3Y*
-14.95%
5Y*
12.25%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SOC vs. MLTX - Yearly Performance Comparison


2026 (YTD)20252024
SOC
Sable Offshore Corp
45.45%-60.61%84.53%
MLTX
MoonLake Immunotherapeutics
36.57%-75.66%-9.80%

Correlation

The correlation between SOC and MLTX is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.03

Correlation (All Time)
Calculated using the full available price history since Feb 16, 2024

0.02

Fundamentals

Market Cap

SOC:

$1.88T

MLTX:

$1.28B

EPS

SOC:

-$0.01

MLTX:

-$3.90

PB Ratio

SOC:

4.47K

MLTX:

5.05

Total Revenue (TTM)

SOC:

$1.27M

MLTX:

$0.00

Gross Profit (TTM)

SOC:

-$11.08M

MLTX:

-$1.49M

EBITDA (TTM)

SOC:

-$337.95M

MLTX:

-$179.84M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SOC vs. MLTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SOC
SOC Risk / Return Rank: 3131
Overall Rank
SOC Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
SOC Sortino Ratio Rank: 4040
Sortino Ratio Rank
SOC Omega Ratio Rank: 3939
Omega Ratio Rank
SOC Calmar Ratio Rank: 2323
Calmar Ratio Rank
SOC Martin Ratio Rank: 2626
Martin Ratio Rank

MLTX
MLTX Risk / Return Rank: 3434
Overall Rank
MLTX Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
MLTX Sortino Ratio Rank: 4949
Sortino Ratio Rank
MLTX Omega Ratio Rank: 6363
Omega Ratio Rank
MLTX Calmar Ratio Rank: 1616
Calmar Ratio Rank
MLTX Martin Ratio Rank: 2323
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SOC vs. MLTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sable Offshore Corp (SOC) and MoonLake Immunotherapeutics (MLTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SOCMLTXDifference
Sharpe ratioReturn per unit of total volatility

+0.20

Sortino ratioReturn per unit of downside risk

-0.35

Omega ratioGain probability vs. loss probability

1.04

1.18

-0.13

Calmar ratioReturn relative to maximum drawdown

-0.54

-0.69

+0.15

Martin ratioReturn relative to average drawdown

-0.85

-0.98

+0.13

SOC vs. MLTX - Sharpe Ratio Comparison

The current SOC Sharpe Ratio is -0.33, which is higher than the MLTX Sharpe Ratio of -0.53. The chart below compares the historical Sharpe Ratios of SOC and MLTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SOCMLTXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.33

-0.53

+0.20

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

0.02

0.12

-0.10

Drawdowns

SOC vs. MLTX - Drawdown Comparison

The maximum SOC drawdown since its inception was -87.52%, roughly equal to the maximum MLTX drawdown of -90.22%. Use the drawdown chart below to compare losses from any high point for SOC and MLTX.


Loading charts...

Drawdown Indicators


SOCMLTXDifference

Max Drawdown

Largest peak-to-trough decline

-87.52%

-90.22%

+2.70%

Max Drawdown (1Y)

Largest decline over 1 year

-87.00%

-89.93%

+2.93%

Max Drawdown (3Y)

Largest decline over 3 years

-90.22%

Max Drawdown (5Y)

Largest decline over 5 years

-90.22%

Current Drawdown

Current decline from peak

-60.27%

-71.81%

+11.54%

Average Drawdown

Average peak-to-trough decline

-30.80%

-29.24%

-1.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

54.76%

63.21%

-8.45%

Volatility

SOC vs. MLTX - Volatility Comparison

Sable Offshore Corp (SOC) has a higher volatility of 27.48% compared to MoonLake Immunotherapeutics (MLTX) at 18.65%. This indicates that SOC's price experiences larger fluctuations and is considered to be riskier than MLTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SOCMLTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.48%

18.65%

+8.83%

Volatility (6M)

Calculated over the trailing 6-month period

96.35%

55.24%

+41.11%

Volatility (1Y)

Calculated over the trailing 1-year period

140.85%

115.84%

+25.01%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

111.43%

91.15%

+20.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

111.43%

86.45%

+24.98%

Dividends

SOC vs. MLTX - Dividend Comparison

Neither SOC nor MLTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SOC vs. MLTX - Financials Comparison

This section allows you to compare key financial metrics between Sable Offshore Corp and MoonLake Immunotherapeutics. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00K400.00K600.00K800.00K1.00M1.20M20222023202420252026
1.27M
0
(SOC) Total Revenue
(MLTX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SOC and MLTX have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SOC has higher volatility (27.48%) compared to MLTX (18.65%). In terms of maximum drawdown, SOC dropped -87.52% vs MLTX's -90.22%.

SOC currently has the higher Sharpe Ratio (-0.33 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SOC and MLTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer